MSD Korea, Daewoong sign co-promotion deal for Vytorin
Published: 2011-07-04 06:58:00
Updated: 2011-07-04 06:58:00
MSD Korea and Daewoong Pharmaceuticals have recently entered into an agreement for the co-marketing of Vytorin for the treatment of high cholesterol in the domestic market following their strategic alliance of Foxamax tablets and Januvia tablets.
Vyrorin contains ezetimibe, a selective inhibit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
